132 related articles for article (PubMed ID: 16179348)
21. Retinoid X receptor expression in skeletal muscle of nondiabetic, obese and type 2 diabetic individuals.
Codner E; Loviscach M; Ciaraldi TP; Rehman N; Carter L; Mudaliar S; Henry RR
Metabolism; 2001 Jul; 50(7):830-4. PubMed ID: 11436190
[TBL] [Abstract][Full Text] [Related]
22. Activation of peroxisome proliferator-activated receptor-gamma and retinoid X receptor inhibits aromatase transcription via nuclear factor-kappaB.
Fan W; Yanase T; Morinaga H; Mu YM; Nomura M; Okabe T; Goto K; Harada N; Nawata H
Endocrinology; 2005 Jan; 146(1):85-92. PubMed ID: 15459115
[TBL] [Abstract][Full Text] [Related]
23. Induction of the fatty acid transport protein 1 and acyl-CoA synthase genes by dimer-selective rexinoids suggests that the peroxisome proliferator-activated receptor-retinoid X receptor heterodimer is their molecular target.
Martin G; Poirier H; Hennuyer N; Crombie D; Fruchart JC; Heyman RA; Besnard P; Auwerx J
J Biol Chem; 2000 Apr; 275(17):12612-8. PubMed ID: 10777552
[TBL] [Abstract][Full Text] [Related]
24. Impaired expression of NADH dehydrogenase subunit 1 and PPARgamma coactivator-1 in skeletal muscle of ZDF rats: restoration by troglitazone.
Jové M; Salla J; Planavila A; Cabrero A; Michalik L; Wahli W; Laguna JC; Vázquez-Carrera M
J Lipid Res; 2004 Jan; 45(1):113-23. PubMed ID: 14563825
[TBL] [Abstract][Full Text] [Related]
25. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
[TBL] [Abstract][Full Text] [Related]
26. Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice.
Lin CH; Kuo YH; Shih CC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099085
[TBL] [Abstract][Full Text] [Related]
27. Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter.
Kim HI; Kim JW; Kim SH; Cha JY; Kim KS; Ahn YH
Diabetes; 2000 Sep; 49(9):1517-24. PubMed ID: 10969836
[TBL] [Abstract][Full Text] [Related]
28. Activation of PPARalpha and PPARgamma reduces triacylglycerol synthesis in rat hepatoma cells by reduction of nuclear SREBP-1.
König B; Koch A; Spielmann J; Hilgenfeld C; Hirche F; Stangl GI; Eder K
Eur J Pharmacol; 2009 Mar; 605(1-3):23-30. PubMed ID: 19248225
[TBL] [Abstract][Full Text] [Related]
29. Vitamin A enhances in vitro Th2 development via retinoid X receptor pathway.
Stephensen CB; Rasooly R; Jiang X; Ceddia MA; Weaver CT; Chandraratna RA; Bucy RP
J Immunol; 2002 May; 168(9):4495-503. PubMed ID: 11970994
[TBL] [Abstract][Full Text] [Related]
30. Potent antidiabetic effects of rivoglitazone, a novel peroxisome proliferator-activated receptor-gamma agonist, in obese diabetic rodent models.
Kanda S; Nakashima R; Takahashi K; Tanaka J; Ogawa J; Ogata T; Yachi M; Araki K; Ohsumi J
J Pharmacol Sci; 2009 Oct; 111(2):155-66. PubMed ID: 19809220
[TBL] [Abstract][Full Text] [Related]
31. Ligands for the peroxisomal proliferator-activated receptor gamma and the retinoid X receptor inhibit aromatase cytochrome P450 (CYP19) expression mediated by promoter II in human breast adipose.
Rubin GL; Duong JH; Clyne CD; Speed CJ; Murata Y; Gong C; Simpson ER
Endocrinology; 2002 Aug; 143(8):2863-71. PubMed ID: 12130549
[TBL] [Abstract][Full Text] [Related]
32. Regulation of aromatase by nuclear receptors.
Yanase T; Mu YM; Nishi Y; Goto K; Nomura M; Okabe T; Takayanagi R; Nawata H
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):187-92. PubMed ID: 11850224
[TBL] [Abstract][Full Text] [Related]
33. Feasibility of structural modification of retinoid X receptor agonists to separate blood glucose-lowering action from adverse effects: studies in KKA(y) type 2 diabetes model mice.
Kakuta H; Ohsawa F; Yamada S; Makishima M; Tai A; Yasui H; Yoshikawa Y
Biol Pharm Bull; 2012; 35(4):629-33. PubMed ID: 22466572
[TBL] [Abstract][Full Text] [Related]
34. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
35. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
[TBL] [Abstract][Full Text] [Related]
36. Modulation of RXR function through ligand design.
Pérez E; Bourguet W; Gronemeyer H; de Lera AR
Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
[TBL] [Abstract][Full Text] [Related]
37. Ligand Activity of Group 15 Compounds Possessing Triphenyl Substituent for the RXR and PPARγ Nuclear Receptors.
Hiromori Y; Ido A; Aoki A; Kimura T; Nagase H; Nakanishi T
Biol Pharm Bull; 2016; 39(10):1596-1603. PubMed ID: 27725436
[TBL] [Abstract][Full Text] [Related]
38. Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor gamma ligand 1-Di(1H-indol-3-yl)methyl-4-trifluoromethylbenzene.
Dawson MI; Ye M; Cao X; Farhana L; Hu QY; Zhao Y; Xu LP; Kiselyuk A; Correa RG; Yang L; Hou T; Reed JC; Itkin-Ansari P; Levine F; Sanner MF; Fontana JA; Zhang XK
ChemMedChem; 2009 Jul; 4(7):1106-19. PubMed ID: 19378296
[TBL] [Abstract][Full Text] [Related]
39. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
[TBL] [Abstract][Full Text] [Related]
40. Ankaflavin: a natural novel PPARγ agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo.
Lee BH; Hsu WH; Chang YY; Kuo HF; Hsu YW; Pan TM
Free Radic Biol Med; 2012 Dec; 53(11):2008-16. PubMed ID: 23022408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
